Effects of dextranase from Spicaria violaceae (IFO 6120) on the polysaccharides produced by oral streptococci and on human dental plaque.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to Y Murayama.
Explore the source record for details and available documents.
BACKGROUND AND PURPOSE: Stronger cellular adhesion on the surface of endovascular devices promotes accelerated healing of aneurysms. The purpose of this in vitro study was to study the cellular interaction on the surface of bioactive Guglielmi detachable coils (GDCs) after using the surface-modification technology, ion implantation. METHODS: Polystyrene (PS) dishes and platinum plates were used to simulate a GDC surface. They were treated with either simple collagen coating or collagen coating followed with ion implantation. Bovine endothelial cells (2-2.5 x 10(4) cells in 1 mL) were suspended in medium supplemented with 10% fetal bovine serum on the PS dishes or platinum plates. Five days after cell seeding, the strength of cell adhesion was evaluated by trypsin treatment and flow shear stress. The cell detachment from the PS and platinum surfaces was observed microscopically. RESULTS: Five days after cell seeding, both simple collagen-coated surfaces and collagen-coated ion-implanted surfaces showed uniform endothelial proliferation. After trypsin treatment, or under flow shear stress, stronger cell adhesion against chemical and flow shear stress was observed on the ion-implanted collagen-coated surface. In contrast, the endothelial cells were detached easily from the non-ion-implanted collagen-coated surface. CONCLUSION: Ion implantation in combination with protein coating improves the strength of surface cell adhesion when exposed to flow shear stress and proteolytic enzymes. Strong endothelial cell adhesion is reported to be important to achieve earlier endothelialization across the neck of an embolized aneurysm with bioactive GDCs. This new technology may improve long-term anatomic outcome in cerebral aneurysms treated with GDCs.
BACKGROUND AND PURPOSE: Ion implantation is a surface-modification technology that creates a borderless surface on protein-coated platinum; this change in physical and chemical properties on the surface of Guglielmi detachable coils (GDCs) appears to enhance cell proliferation and adhesion. Our purpose was to evaluate the effect of ion implantation on GDCs in an experimental aneurysm model. METHODS: GDCs were coated with either type I collagen, fibronectin, vitronectin, laminin, or fibrinogen. Using He+ or Ne+ 1 x 10(14-15) ions/cm2, ion implantation was performed on these protein-coated GDCs (GDC-Is). A total of 56 experimental aneurysms were constructed microsurgically in the common carotid arteries of 28 swine. These experimental aneurysms were embolized with standard GDCs (n = 23), collagen GDC-Is (n = 11), vitronectin GDC-Is (n = 6), laminin GDC-Is (n = 4), fibrinogen GDC-Is (n = 6), and fibronectin GDC-Is (n = 6). The animals were sacrificed at day 14 after coil embolization. The physical properties of the new coils (friction on delivery, deployment into aneurysms, trackability, etc) and the development of tissue scarring and neoendothelium across the aneurysm's orifice were evaluated macroscopically and microscopically. RESULTS: No evidence of increased coil friction/stiffness was observed during delivery of GDC-Is through microcatheters in this aneurysm model. A more intense scar formation and neoendothelium at the neck of aneurysms were observed macroscopically when treated with GDC-Is. Significant differences in the proportion of neck coverage between standard GDCs (48.3% +/- 20.5%) and all GDC-I groups were observed (collagen GDC-I-89.4% +/- 14.9%, P < .01; vitronectin GDC-I-71.5% +/- 7.0%, P < .05; laminin GDC-I-76.5% +/- 11.0%, P < .05; fibrinogen GDC-I-74.8% +/- 13.9%, P < .05; fibronectin GDC-I-87.5% +/- 15.0%, P < .01). Light microscopy showed a well-organized fibrous tissue bridging the aneurysm's neck when using GDC-Is, whereas only a fibrin-like thin layer covered the standard GDC surfaces. CONCLUSION: GDC-Is indicated a more intense inflammatory response in the aneurysm body and dome and faster re-endothelial coverage of the neck of the aneurysm. This accelerated histologic response may decrease the chances of coil compaction and aneurysm recanalization. This technology may improve anatomic and clinical outcomes in patients harboring intracranial aneurysms.
The effects on spontaneous motor activity of the pattern of restricted feeding, far-infrared ray (FIR) irradiation or free access in drinking water containing Sasa Health, a bamboo grass leafextract, were examined in SHN male mice at 2-3 months of age. In mice whose diet was restricted to 60% of the control, fed at 9:00 or 17:00 hours, the level of spontaneous behaviour was elevated 1 hour before the respective feeding time (8:00 or 16:00 hours). The activity was stimulated by FIR in both the control and food-restricted mice, but to a much higher degree in the latter. Treatment with Sasa Health in drinking water lowered the elevated activity level in food-restricted mice. Plasma component levels and organ weights were modulated by FIR or Sasa Health. The findings revealed that, not only the restricted feeding itsel, but also its pattern, significantly affected behaviour and that FIR and Sasa Health modified the deleterious effects of restricted feeding.
We used cross circulation as an assist method for orthotopic heart transplantation in eight dogs. Seven of the eight dogs could be extubated on the first to third postoperative day and were able to eat and walk several hours after extubation. The survival times and the causes of death in these eight dogs were as follows: 436 days (alive), 5 days (sudden death), 17 days (rejection), 17 days (pyothorax), 3 days (accidental death), 59 days (rejection), 19 days (pneumothorax), and 188 days (alive). None of the dogs died of any problems related to the use of cross circulation. Hematologic and biochemical studies revealed that the CK, CK-MB, LDH, GOT, GPT, and lactate levels increased shortly after the operation and returned to the preoperative values within 14 days. The blood urea nitrogen, creatinine, amylase, hematocrit, and total protein levels remained almost unchanged. No free hemoglobin was detected. These findings indicated that no severe damage occurred to the recipient's organs. The key factors for performing successful cross circulation are as follows: (1) The body weight of the support dog should be at least three times that of the recipient. (2) The systolic pressure of the support dog and the pressure gradient between the support and the recipient should be kept above 150 mm Hg and 50 mm Hg, respectively. (3) The flow rate in the arterial tube should be maintained at between 30% and 50% of the basal cardiac output of the recipient. In conclusion, cross circulation is a suitable assist method for orthotopic heart transplantation in the dog.
To overcome the disadvantages of glutaraldehyde (GA), new cross-linking reagents, polyepoxy compounds (PC), were introduced and their effects on the antigenicity and immunogenicity of biomaterials were investigated. In the qualitative study, antigenicity of type I collagen in bovine arteries treated with GA or glycerol polyglycidyl ether (GPE), a kind of PC, was detected using a fluorescent antibody technique. To evaluate the immunogenicity quantitatively, DDY mice were twice immunized with homogenates of GA, GPE, or untreated dog arteries. Using their sera collected 10 and 90 days after the last immunization as primary antibodies, the dogs' peripheral lymphocytes were stained with FITC labeled anti-mouse IgG antibodies against shared antigens on arteries and lymphocytes. Percentages of stained lymphocytes were then analyzed with flow cytofluorometry. In both qualitative and quantitative studies, extremely low antigenicity and immunogenicity were shown in GA or GPE treated arteries. It is therefore suggested that GPE is an ideal cross-linking reagent for vascular and valvular xenografts and is applicable to clinical use.